STING1 and neoplasm: In ovarian cancers, BRCA1/2-mutated tumors are associated with high tumor-infiltrating lymphocytes demonstrating improved prognosis, and in addition to elevated mutations would be anticipated to have more frequent micronuclei, leading to activation of the STING response116.